Concepedia

Publication | Closed Access

Valganciclovir Preemptive Therapy for the Prevention of Cytomegalovirus Disease in High-Risk Seropositive Solid-Organ Transplant Recipients

DOI

51

Citations

23

References

2006

Year

Carmen Díaz‐Pedroche, Carlos Lumbreras, Rafael San Juan, María Dolores Folgueira, Amado Andrés, Juan F. Delgado, J.C. Meneu, José Morales, A. Moreno-Elola, Susana Hernando,
Transplantation

Abstract

VGCV is safe and highly efficacious in the prevention of CMV disease in high-risk seropositive organ transplant recipients.

References

YearCitations

Page 1